drugset / Trial / NCT00313859

Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC

NCT00313859

Phase 2 Completed 50 enrolled Samsung Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is designed to assess the tolerability and efficacy of simvastatin plus FOLFIRI (irinotecan, 5-FU, leucovorin) in metastatic colorectal cancer patients.

Timeline

Start
2005-09
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule